Payments and support provided by Grünenthal in the UK
Grünenthal Ltd. is a committed member of the Association of the British Pharmaceutical Industry (ABPI). As such we adhere to the requirements of the ABPI Code of Practice in the conduct of our business. As part of this commitment, we declare annually all payments made to UK healthcare professionals (HCPs) by the UK organisation and our affiliate companies overseas. In addition we provide transparency on our interactions with, and support of patient organisations, and any grants and donations we provide to institutes and organisations. The figures below do not currently include payments made to HCPs for research and development or market research when the participant is unknown to Grünenthal. Grünenthal does not support individual HCPs to attend third party scientific meetings and medical congresses.
Further information on the requirements of the ABPI Code of Practice and its enforcement can be accessed from the Prescription Medicines Code of Practice Authority’s website: www.pmcpa.org.uk. The ABPI have also produced a leaflet regarding the public declaration of payments made to HCPs which can be downloaded from the website.
As per the ABPI Code of Practice, all transfers of value to UK HCPs and HCOs (including those provided as grants or donations) made in 2015 and subsequent years are to be disclosed on a central ABPI portal. The portal can be accessed using this web address: www.disclosureuk.org.uk. The content will be updated by 1st July each year for data from the preceding year. Support provided to patient organisations and other organisations in our local community will continue to be disclosed below.
Support of patient organisations and other groups in our local community in 2017
|All-Party Parliamentary Health Group||Corporate sponsorship||£ 2,000|
|Arthritis and Musculoskeletal Alliance||Corporate sponsorship||£10,000|
|Arthritis Care Wales||Financial support of a Welsh Assembly meeting to raise awareness of gout (funded through Positif Politics)||£ 600|
|Bladder Health UK||Advisory fees||£450|
|British Society for the Study of Vulval Disease||Advisory fees||€1206.15|
|Chronic Pain Policy Coalition||Corporate sponsorship||£8,000|
|CRPS UK||Financial support of a pain workshop||£200|
|CRPS UK||Speaker fees including preparation and delivery time for two representatives||£800|
|European Parkinson's Disease Association (EPDA)||Corporate donation||£10,000|
|Helen & Douglas House||Corporate donation to Helen & Douglas House||£250|
|Helen & Douglas House||£10 donation for every completed module of Grünenthal developed educational programme, Change Pain||£3,490|
|Limbless Association||Advisory fees||£1,700|
|Reading and District Hospitals Charity||2017 Pain Awards winner||£5,000|
|South Tees Hospitals NHS Foundation||2017 Pain Awards winner||£2,000|
|The Patients Association||Corporate sponsorship||£10,000|
|The Patients Association||Financial support of a parliamentary reception to launch the ‘Attitudes to Pain and Pain Management in Care Homes’ report||£9,660|
|UK Gout Society||Grant to support the production, printing and distribution of patient materials by the society||£5,000|
|UK Gout Society||Financial support of a parliamentary reception to raise awareness of gout||£10,000|
|UK Gout Society||Financial support of a Welsh Assembly meeting to raise awareness of gout||£600|
|Walton Centre NHS Foundation Trust||2017 Pain Awards winner||£10,000|
Grünenthal have also provided a service evaluation tool to support the local evaluation of the effectiveness of analgesics already used in routine clinical practice. This service is provided to support and inform local decision-making, and has been utilised by the following HCOs:
- St Woolos Hospital, Newport.
- Whitegate Drive Health Centre, Blackpool.
- Aintree University Hospital, Liverpool.
- NHS Highland Chronic Pain Service.